July 30, 2019

Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System

• Resting the heart while perfusing the kidneys, Aortix aims to treat heart failure symptoms by disrupting the cardiorenal syndrome cycle • Potential to offer significant advantages for patients with acute decompensated heart failure (ADHF) who also have worsening renal function

Read More
Older Posts